Insulin resistance (including lipodystrophy)
Gene: CAV1EnsemblGeneIds (GRCh38): ENSG00000105974
EnsemblGeneIds (GRCh37): ENSG00000105974
OMIM: 601047, Gene2Phenotype
CAV1 is in 7 panels
3 reviews
David Savage (IMS MRL, Uni. Cambridge)
Robert Semple (University of Cambridge)
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Generalised Lipodystrophy
Publications
- PMID: 18211975
Sarah Leigh (Genomics England Curator)
Comment when marking as ready: Associated with phenotypes in OMIM and Lipodystrophy, congenital generalized, type 3, 612526 in G2P. Two variant reported (one each in Lipodystrophy, congenital generalized, type 3, 612526 and Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome 606721). Phenotype does not match criteria as it does not include Acanthosis nigricansCreated: 11 Aug 2016, 11:45 a.m.
Comment on phenotypes: Also associated with Pulmonary hypertension, primary, 3, 615343Created: 11 Aug 2016, 11:40 a.m.
Details
- Sources
-
- Expert Review Red
- Radboud University Medical Center, Nijmegen
- Phenotypes
-
- Lipodystrophy, congenital generalized, type 3, 612526
- Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome 606721
- OMIM
- 601047
- Clinvar variants
- Variants in CAV1
- Penetrance
- Complete
- Publications
- Panels with this gene
History Filter Activity
panel promoted to version 1
Sarah Leigh (Genomics England Curator)Promoted to version 1 12/08/2016
Gene classified by Genomics England curator
Sarah Leigh (Genomics England Curator)This gene has been classified as Red List (Low Evidence).
Set publications
Sarah Leigh (Genomics England Curator)Publications for CAV1 were set to 18211975
Set Phenotypes
Sarah Leigh (Genomics England Curator)Phenotypes for CAV1 were set to Lipodystrophy, congenital generalized, type 3, 612526; Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome 606721
Added New Source
Ellen McDonagh (Genomics England Curator)CAV1 was added to Insulin resistance (including lipodystrophy) panel. Sources: Radboud University Medical Center, Nijmegen